» Articles » PMID: 30617565

Tobacco Dependence is Associated with Increased Risk for Multi-morbid Clustering of Posttraumatic Stress Disorder, Depressive Disorder, and Pain Among Post-9/11 Deployed Veterans

Overview
Specialty Pharmacology
Date 2019 Jan 9
PMID 30617565
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Tobacco use is highly prevalent among individuals with posttraumatic stress disorder (PTSD), depressive disorders, and pain. Research has revealed pairwise relationships among these conditions but has not examined more complex relationships that may influence symptom severity, chronicity, and treatment outcome.

Objective: To examine the clustering of current PTSD, depressive disorders, and clinically significant pain according to current tobacco use and dependence among post-9/11 deployed veterans.

Methods: Logistic regression was used to examine the clustering of these conditions in relationship to current tobacco use/dependence, while adjusting for age and total combat exposure, in 343 post-9/11 deployed veterans enrolled in the Translational Research Center for TBI and Stress Disorders (TRACTS) cohort (Mage = 32.1 + 8.3 years; 38% current tobacco use; 25% low and 12% moderate/high tobacco dependence).

Results: A three-way clustering of PTSD, depressive disorder, and pain was more likely than any single or pairwise combination of these conditions in moderate/high tobacco-dependent veterans compared to tobacco non-users (adjusted ORs = 3.50 to 4.18). This multi-morbidity cluster also was associated with increased PTSD severity.

Conclusions: Moderate to high dependence on tobacco is associated with substantially increased clustering of PTSD, depression, and clinically significant pain in veterans. Research examining synergistic interactions among these conditions, biological vulnerabilities shared among them, and the direct impact of tobacco use on the pathophysiology of PTSD, depression, and pain is needed. The results of such work may spur development of more effective integrated treatments to reduce the negative impact of these multi-morbid conditions on veterans' wellbeing and long-term health.

Citing Articles

Cigarette Smoking and Depression Among U.S. Veterans: Longitudinal Associations With Posttraumatic Stress Disorder.

Tran D, Davis J, Tucker J, Bricker J, Lee D, Fitzke R Nicotine Tob Res. 2023; 25(8):1496-1504.

PMID: 37094359 PMC: 10347971. DOI: 10.1093/ntr/ntad064.


Pleiotropic endophenotypic and phenotype effects of GABAergic neurosteroid synthesis deficiency in posttraumatic stress disorder.

Rasmusson A, Novikov O, Brown K, Pinna G, Pineles S Curr Opin Endocr Metab Res. 2023; 25.

PMID: 36909842 PMC: 10004350. DOI: 10.1016/j.coemr.2022.100359.


Identifying co-occurrence and clustering of chronic diseases using latent class analysis: cross-sectional findings from SAGE South Africa Wave 2.

Chidumwa G, Maposa I, Corso B, Minicuci N, Kowal P, Micklesfield L BMJ Open. 2021; 11(1):e041604.

PMID: 33514578 PMC: 7849898. DOI: 10.1136/bmjopen-2020-041604.

References
1.
Kaminska M, Harris J, Gijsbers K, Dubrovsky B . Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. Implications for depression. Brain Res Bull. 2000; 52(3):229-34. DOI: 10.1016/s0361-9230(00)00251-3. View

2.
Kubany E, Haynes S, Leisen M, Owens J, Kaplan A, Watson S . Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire. Psychol Assess. 2000; 12(2):210-24. DOI: 10.1037//1040-3590.12.2.210. View

3.
Breslau N, Davis G, Peterson E, Schultz L . A second look at comorbidity in victims of trauma: the posttraumatic stress disorder-major depression connection. Biol Psychiatry. 2000; 48(9):902-9. DOI: 10.1016/s0006-3223(00)00933-1. View

4.
Lasser K, Boyd J, Woolhandler S, Himmelstein D, McCormick D, Bor D . Smoking and mental illness: A population-based prevalence study. JAMA. 2000; 284(20):2606-10. DOI: 10.1001/jama.284.20.2606. View

5.
Leonard S, Adler L, Benhammou K, Berger R, Breese C, Drebing C . Smoking and mental illness. Pharmacol Biochem Behav. 2002; 70(4):561-70. DOI: 10.1016/s0091-3057(01)00677-3. View